Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR): a single-arm phase II trial

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-025-65162-8
Affiliations:
3
Authors:
16
Go to article
Institutions Authors Share
The Sixth Affiliated Hospital, SYSU, China
16.000000
16.000000
 1.00
Interested in Oncology and Carcinogenesis?